Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3 results about "Abnormal liver function" patented technology

A nutritional composition based on marine shrimp peptides for anti-obesity and improving metabolic syndrome

PendingCN122350339ABiotechnologyNutrition
The present application relates to the field of biological medicine and functional food, and discloses a kind of nutrition composition based on marine shrimp peptide for anti-obesity and improving metabolic syndrome;Including: Chinese tube whip shrimp peptide active component and pharmaceutically acceptable adjuvant, the Chinese tube whip shrimp meat protein is used as raw material, and the Chinese tube whip shrimp meat protein is prepared by alkaline protease enzymolysis, and the Chinese tube whip shrimp meat protein contains peptide segment with molecular weight less than 1 kDa, and APPPPP, HPPPP and MPLPP can be detected.The pharmaceutical composition can reduce the weight and fat tissue weight under the state of obesity, improve dyslipidemia, abnormal liver function and liver steatosis, reduce oxidative stress level, improve intestinal mucosal barrier damage and intestinal permeability increase, and regulate intestinal flora structure change.The active component in the present application is clear in origin, and the preparation process is clear, has the synergistic effect from lipid metabolism regulation, liver protection to intestinal barrier improvement, and can be used for preparing medicine for preventing or treating obesity and improving metabolic syndrome.
Owner:XIANGHU LABORATORY

Use of a mitochondrial transplant formulation for the preparation of a medicament for the treatment of non-alcoholic fatty liver disease

PendingCN122342764ALiver functionsSomatic cell
The present application relates to the application of mitochondrial transplantation preparation in the preparation of a drug for treating non-alcoholic fatty liver disease, wherein the mitochondrial transplantation preparation comprises active mitochondria isolated from healthy donor cells, and has normal membrane potential and mitochondrial respiratory function. In vivo experiments on a non-alcoholic fatty liver mouse model prove that tail vein injection of the mitochondrial transplantation preparation of the present application can effectively reduce the weight of the mouse, improve the fatty liver condition of the mouse, reduce the accumulation of fat in the liver tissue, and at the same time restore the abnormal liver function of the non-alcoholic fatty liver mouse.
Owner:SHANGHAI MICROZHENZI BIOTECHNOLOGY CO LTD

Anti-aging, anti-oxidation and blood fat reducing enzyme liquid and preparation method thereof

PendingCN122004455AFood scienceBiotechnologyGinkgo nut
The invention belongs to the technical field of food fermentation, and discloses an anti-aging, anti-oxidation and blood fat-reducing enzyme liquid and a preparation method thereof. The enzyme liquid is prepared by taking 2-5 parts of hawthorn, 2-5 parts of apple, 1-3 parts of lemon, 0.8-1.5 parts of ginkgo and 1.5-2.5 parts of broken rock sugar as main raw materials, supplementing mountain spring water and honey, and performing raw material pretreatment, primary constant-temperature fermentation and secondary constant-temperature fermentation. The ginkgo seeds are boiled to remove toxins, the primary fermentation is carried out at 28-35 DEG C for 60-90 days, and the secondary fermentation is carried out at 25-32 DEG C for 25-35 days. The prepared enzyme liquid is yellowish, transparent and bright and fragrant in smell, has the remarkable effects of resisting oxidation and aging and assisting in reducing blood fat, can improve intestinal flora and whiten skin, and is suitable for auxiliary conditioning of hyperlipidemia, nephritis and abnormal liver function. The invention has the advantages of scientific formula, controllable process, high safety and good stability, and is suitable for industrial production and market promotion.
Owner:SHENZHEN QIANZHIBEN HEALTH MANAGEMENT CO LTD